SCHEMBL514009

SCHEMBL514009

CCC(CC)(c1coc(-c2cccs2)n1)P(=O)(O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.48
HDAC6 Q9UBN7 2/20 0.48
HDAC8 Q9BY41 1/20 0.48
S1PR1 P21453 1/20 0.44
S1PR3 Q99500 1/20 0.44
VDR P11473 1/20 0.37
ALDH1A1 P00352 7/20 0.36
MAPT P10636 5/20 0.36
HPGD P15428 5/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KDM4E B2RXH2 8/20 0.36
HSD17B10 Q99714 4/20 0.36
SMN1; SMN2 Q16637 6/20 0.36
NPC1 O15118 5/20 0.36
RAB9A P51151 5/20 0.36
FBP1 P09467 1/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL513443 0.78 NPC1 (0.44) HDAC1HDAC6ALDH1A1MAPTNPSR1
SCHEMBL512899 0.76 KDM4E (0.48) HDAC1HDAC6ALDH1A1MAPTHPGD
SCHEMBL512797 0.76 KDM4E (0.47) ALDH1A1MAPTHPGDHTTNPSR1
SCHEMBL514330 0.72 NPC1 (0.46) HDAC1HDAC6HDAC8MAPTKDM4E
SCHEMBL513766 0.72 ALDH1A1 (0.40) HDAC1HDAC6HDAC8ALDH1A1HPGD
SCHEMBL15203949 0.69 TSHR (0.38) HDAC1ALDH1A1MAPTHTTKDM4E
SCHEMBL5010542 0.68 PGK1 (0.53) ALDH1A1GAAMEN1KMT2A
SCHEMBL10247601 0.68 HDAC1 (0.45) HDAC1HDAC6HDAC8S1PR1S1PR3
SCHEMBL5758856 0.66 HDAC1 (0.52) HDAC1HDAC6HDAC8S1PR1S1PR3
SCHEMBL3558527 0.65 HDAC1 (0.71) HDAC1HDAC6HDAC8ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120028931-A1 HETEROCYCLIC M-GLU5 ANTAGONISTS RECORDATI IRELAND LIMITED (IE) 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028931-A1 HETEROCYCLIC M-GLU5 ANTAGONISTS OPRM1, GRM5, OPRD1 HDAC1 1703/4885HDAC6 1642/4885HDAC8 2410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.